Cisbio

Life Sciences solutions for pharmaceutical and biological research

Cisbio operates mostly in Life Sciences Drug Discovery. It also has a small In-Vitro Diagnostics business unit. It serves clients through both a direct sales organization and distributors. It has 3 overseas subsidiaries (USA, China, Japan). Life Sciences activities serve big pharmas as well as biotechs and university research institutes. They focus on developing reagents at early phases of the biopharma R&D value chain, when biotechs/pharmas perform series of key tests to bring therapeutic candidates to clinical trials. The group IVD activities manufacture reagents to perform tests on biological samples (e.g.: blood, urine, tissues) to diagnose diseases in medical laboratories.

Date d'entrée au capital

June 2016

Type de deal

LMBO

Chiffre d'affaires

45m€

Nombre d'employés

210

Date de cession

October 2020

Type de cession

Industrial sale to PerkinElmer

« La “Certificazione B Corporation” è un marchio che viene concesso in licenza da B Lab, ente privato no profit, alle aziende che, come la nostra, hanno superato con successo il B Impact Assessment (“BIA”) e soddisfano quindi i requisiti richiesti da B Lab in termini di performance sociale e ambientale, responsabilità e trasparenza. Si specifica che B Lab non è un organismo di valutazione della conformità ai sensi del Regolamento (UE) n. 765/2008 o un organismo di normazione nazionale, europeo o internazionale ai sensi del Regolamento (UE) n. 1025/2012. I criteri del BIA sono distinti e autonomi rispetto agli standard armonizzati risultanti dalle norme ISO o di altri organismi di normazione e non sono ratificati da parte di istituzioni pubbliche nazionali o europee. »

“Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.